PR
Media
-
HEM Pharma, selected for the 'microbiome-based original technology development' ..2023.05.02 -
HEM Pharma, selected as a project to establish a foundation for personalized nut..2023.05.02 -
[Seminar] Microbiome industry seminar successfully completed2023.04.05 -
HEM Pharma submits IND for phase 2a clinical trial of a new antidepressant candi..2023.03.14 -
HEM Pharma approved for phase 2 clinical trial in Australia for treatment of low..2023.03.06 -
[Monthly Magazine] Interview with CEO Josep Ji of Monthly People, February2023.02.10 -
[Broadcast] PAX Economic TV "Close-up corporate site"2023.01.25 -
HEM Pharma “Strengthening Microbiome Business Competitiveness”2023.01.25 -
HEM Pharma, signs a business agreement with LogMe for the development of health..2022.12.05 -
[Broadcast] 'Hope TV SBS' Sharing to save the world - Eco-friendly management c..2022.11.24 -
HEM Pharma acquired ‘Innobiz Grade A’, a technology innovation certification sys..2022.10.28 -
Sejong City attracts 598.2 billion won investment with 13 semiconductor and med..2022.09.30
- Pohang
-
Address. 102, Business incubator center, Handong Global University, 558, Handong-ro, Heunghae-eup, Buk-gu, Pohang-si, Gyeongsangbuk-do, Republic of Korea
- Gwanggyo
- Address. 404, Ace Gwanggyo Tower 3, 77, Changnyong-daero 256-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea
(C) 2022.HEM Pharma Inc. All rights reserved.